Quralis

Developing drugs & CSF cartridge device for treating amyotrophic lateral sclerosis (ALS)

placeCambridge, Massachusetts, United States calendar_todayFounded 2016 groups38 employees language quralis.com

Registered entities

Innovation

10 patent families — focus: Chemistry & metallurgy, Human necessities; filing pace steady. Cited 157 times.

YearFilings
20202
20213
20223
20238
20245
20253
20264

Social engagement

Social engagement: 12.7K social following, 5 posts in the last 12 months — below the industry typical range.

Investor mix

23 investors on record; lead investors include Polaris Partners, Mission BioCapital, MP Healthcare Venture Management, Droia Ventures.

Investor typeCountShare
Venture capital1878%
Private equity29%
Accelerator & incubator14%
Other / undisclosed29%

Recent activity

30 Jun 2026
Event
Advancing Novel Therapeutics in Neuroscience: Innovation to Translation
Coming soon